Table 1 Base line characteristics of the study population
Study 1 | Study 2 | Study 3 | Study 4 | Study 5 | Study 6 | |
|---|---|---|---|---|---|---|
Year | 2004 | 2006 | 2007 | 2008 | 2010 | 2011 |
Study period | May | Jun | May – Nov | Aug-Oct | Oct-Dec + Jan 2011 | Apr-Jun |
Patients included (n) | 106 | 50 | 258 | 200 | 33 | 130 |
Sex, female patients (%) | 51 | 62 | 54 | 49 | 49 | 50 |
Age, months, median (range) | 31 (6–135) | 48 (12–119) | 31 (4–60) | 36 (2–124) | N.D | 60 (12–120) |
Weight, kg, median (range) | 12 (6–33) | 13 (8–30) | 12 (5–21) | 12 (5–33) | 13 (6–29) | 15 (8–32) |
Parasites/μL, geometric mean (range) | 21,595 (2,000-160,000) | 36,885 (2,120-200,400) | 43,259 (2,700-192,320) | 17,531 (2,000-192,000) | 18,537 (2,400-185,120) | 10,198 (1,080-112,800) |
Slide positivity rate, microscopy positive/screened (%) | 175/434 (40%) | 148/277 (53%) | 718/1403 (51%) | 473/745 (63%) | 99/588 (17%) | 599/1002 (60%) |